AKARX

akarx-logo

AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.

#SimilarOrganizations #People #Financial #More

AKARX

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2005-01-01

Address:
Paramus, New Jersey, United States

Country:
United States

Status:
Active

Total Funding:
21.1 M USD


Similar Organizations

anthos-therapeutics-logo

Anthos Therapeutics

Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.

resolvyx-pharmaceuticals-logo

Resolvyx Pharmaceuticals

Resolvyx Pharmaceuticals develops therapeutics with small molecule lipid mediators for the treatment of inflammatory diseases.

Current Employees Featured

not_available_image

Robert E. Desjardins
Robert E. Desjardins Co-Founder @ AkaRx
Co-Founder

Founder


not_available_image

Robert E. Desjardins

Investors List

sutter-hill-ventures_image

Sutter Hill Ventures

Sutter Hill Ventures investment in Series A - AkaRx

interwest-partners_image

InterWest Partners

InterWest Partners investment in Series A - AkaRx

interwest-partners_image

InterWest Partners

InterWest Partners investment in Series A - AkaRx

sutter-hill-ventures_image

Sutter Hill Ventures

Sutter Hill Ventures investment in Series A - AkaRx

interwest-partners_image

InterWest Partners

InterWest Partners investment in Series A - AkaRx

sutter-hill-ventures_image

Sutter Hill Ventures

Sutter Hill Ventures investment in Series A - AkaRx

More informations about "AkaRx" on Search Engine